Human trials set for experimental HIV vaccine - FOX Carolina 21

Human trials set for experimental HIV vaccine

Updated:
© iStockphoto.com © iStockphoto.com

(HealthDay News) -- An experimental HIV vaccine protected animals from dozens of strains of HIV. And a human trial of the vaccine is expected to begin in the second half of 2019, according to U.S. researchers.

The vaccine targets a vulnerable site on HIV -- the virus that causes AIDS -- and triggered antibody production in mice, guinea pigs and monkeys, according to researchers with the U.S. National Institute of Allergy and Infectious Diseases (NIAID).

The scientists "used their detailed knowledge of the structure of HIV to find an unusual site of vulnerability on the virus and design a novel and potentially powerful vaccine," NIAID director Dr. Anthony Fauci said in an agency news release.

"This elegant study is a potentially important step forward in the ongoing quest to develop a safe and effective HIV vaccine," he added.

The scientists are making refinements to the vaccine, such as boosting its potency, to produce a version that's suitable for testing in people.

The study, led by Peter Kwong and Dr. John Mascola of the NIAID Vaccine Research Center, was published online June 4 in the journal Nature Medicine.

More information

The U.S. Centers for Disease Control and Prevention has more on HIV prevention.

Copyright © 2018 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by Frankly
Fox Carolina
Powered by WorldNow CNN
All content © 2018, WHNS; Greenville, SC. (A Meredith Corporation Station) . All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.